Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:2501470rdf:typepubmed:Citationlld:pubmed
pubmed-article:2501470lifeskim:mentionsumls-concept:C0034693lld:lifeskim
pubmed-article:2501470lifeskim:mentionsumls-concept:C0006104lld:lifeskim
pubmed-article:2501470lifeskim:mentionsumls-concept:C0205147lld:lifeskim
pubmed-article:2501470lifeskim:mentionsumls-concept:C0013030lld:lifeskim
pubmed-article:2501470lifeskim:mentionsumls-concept:C0028351lld:lifeskim
pubmed-article:2501470lifeskim:mentionsumls-concept:C0243127lld:lifeskim
pubmed-article:2501470lifeskim:mentionsumls-concept:C0392747lld:lifeskim
pubmed-article:2501470lifeskim:mentionsumls-concept:C0443172lld:lifeskim
pubmed-article:2501470lifeskim:mentionsumls-concept:C0443331lld:lifeskim
pubmed-article:2501470pubmed:issue2lld:pubmed
pubmed-article:2501470pubmed:dateCreated1989-8-22lld:pubmed
pubmed-article:2501470pubmed:abstractTextUsing high performance liquid chromatography with electrochemical detection, the levels of 3-methoxy-4-hydroxyphenylethyleneglycol (MHPG), 3,4-dihydroxyphenylacetic acid (DOPAC) and 3,4-dihydroxyphenylalanine (DOPA) were determined in various brain regions of the rat 1 h after nicotine administration. Nicotine (1 mg/kg, s.c.) produced an increase in MHPG concentrations in the occipital cortex, hippocampus, striatum, hypothalamus, thalamus, midbrain, pons/medulla and cerebellum. This alkaloid at the same dose also caused an increase in DOPAC concentrations in the hypothalamus, thalamus and pons/medulla. The nicotine-induced increase in MHPG and DOPAC concentrations in the brain regions was inhibited by pretreatment with mecamylamine (5 mg/kg, i.p.) but not by hexamethonium (10 mg/kg, i.p.). Nicotine (1 mg/kg, s.c.) produced an increase in DOPA concentrations under DOPA decarboxylase inhibition with NSD-1015 (200 mg/kg, i.p.) in the hypothalamus, thalamus and pons/medulla. These results indicate that nicotine can increase the turnover of noradrenaline and dopamine in various brain regions of the rat and this effect is mediated via activation of central nicotinic receptors.lld:pubmed
pubmed-article:2501470pubmed:languageenglld:pubmed
pubmed-article:2501470pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2501470pubmed:citationSubsetIMlld:pubmed
pubmed-article:2501470pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2501470pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2501470pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2501470pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2501470pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2501470pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2501470pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2501470pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2501470pubmed:statusMEDLINElld:pubmed
pubmed-article:2501470pubmed:monthFeblld:pubmed
pubmed-article:2501470pubmed:issn0386-846Xlld:pubmed
pubmed-article:2501470pubmed:authorpubmed-author:KubaJJlld:pubmed
pubmed-article:2501470pubmed:authorpubmed-author:KurahashiKKlld:pubmed
pubmed-article:2501470pubmed:authorpubmed-author:AmanoHHlld:pubmed
pubmed-article:2501470pubmed:authorpubmed-author:MisuYYlld:pubmed
pubmed-article:2501470pubmed:issnTypePrintlld:pubmed
pubmed-article:2501470pubmed:volume12lld:pubmed
pubmed-article:2501470pubmed:ownerNLMlld:pubmed
pubmed-article:2501470pubmed:authorsCompleteYlld:pubmed
pubmed-article:2501470pubmed:pagination107-12lld:pubmed
pubmed-article:2501470pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:2501470pubmed:meshHeadingpubmed-meshheading:2501470-...lld:pubmed
pubmed-article:2501470pubmed:meshHeadingpubmed-meshheading:2501470-...lld:pubmed
pubmed-article:2501470pubmed:meshHeadingpubmed-meshheading:2501470-...lld:pubmed
pubmed-article:2501470pubmed:meshHeadingpubmed-meshheading:2501470-...lld:pubmed
pubmed-article:2501470pubmed:meshHeadingpubmed-meshheading:2501470-...lld:pubmed
pubmed-article:2501470pubmed:meshHeadingpubmed-meshheading:2501470-...lld:pubmed
pubmed-article:2501470pubmed:meshHeadingpubmed-meshheading:2501470-...lld:pubmed
pubmed-article:2501470pubmed:meshHeadingpubmed-meshheading:2501470-...lld:pubmed
pubmed-article:2501470pubmed:meshHeadingpubmed-meshheading:2501470-...lld:pubmed
pubmed-article:2501470pubmed:meshHeadingpubmed-meshheading:2501470-...lld:pubmed
pubmed-article:2501470pubmed:meshHeadingpubmed-meshheading:2501470-...lld:pubmed
pubmed-article:2501470pubmed:meshHeadingpubmed-meshheading:2501470-...lld:pubmed
pubmed-article:2501470pubmed:meshHeadingpubmed-meshheading:2501470-...lld:pubmed
pubmed-article:2501470pubmed:meshHeadingpubmed-meshheading:2501470-...lld:pubmed
pubmed-article:2501470pubmed:year1989lld:pubmed
pubmed-article:2501470pubmed:articleTitleNicotine-induced regional changes in brain noradrenaline and dopamine turnover in rats.lld:pubmed
pubmed-article:2501470pubmed:affiliationDepartment of Pharmacology, Yokohama City University School of Medicine, Japan.lld:pubmed
pubmed-article:2501470pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:2501470pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed